Esperion Therapeutics, Inc. ESPR 深 沪
等待开盘 08-19 09:30:00 美东时间
3.18
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 3.18
- 总市值 8.19亿
- 52周最高 4.175
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.3435
- 委 比 0.00%
- 总股本 2.58亿
- 历史最高 120.96
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.6925
- 每 手 1
- 风险率 0.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Merck Just Won The Race For The First Cholesterol Pill: What It Means For Your Heart And Your Portfolio
For the tens of millions of Americans who cannot push their LDL cholesterol (trivially known as "bad cholesterol") low enough on statins alone, the strongest backup has meant needles. That changed on July 16, 2026, when the U.S. Food and Drug Administration approved the first oral PCSK9 inhibitor, a...
07-21 05:11
Esperion Presents Data From Phase 2 Trial Of Bempedoic Acid In Children Along With Post Hoc Analysis From CLEAR Outcomes At European Atherosclerosis Society Congress 2026
Esperion (NASDAQ: ESPR) today announced the presentation of results from a Phase 2 study of bempedoic acid in children, along with an additional post hoc analysis from CLEAR Outcomes describing patient traits associated
05-26 20:03
Esperion Therapeutics To Present Two New Analyses On Various Applications Of Bempedoic Acid At The European Atherosclerosis Society (EAS) Congress 2026 May 24-27
Original ResearchAbstract Title: Abstract #: Location: Date & Time:
05-13 20:06
Needham Downgrades Esperion Therapeutics to Hold
Needham analyst Serge Belanger downgrades Esperion Therapeutics (NASDAQ:ESPR) from Buy to Hold.
05-05 03:05
美股大行评级 | 苹果获多家机构上调目标价，最高至335美元；闪迪获华尔街大行看多至2000美元
今日重点评级关注：Benchmark：维持史密斯微软件"买入"评级，目标价从2美元升至2.5美元；Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元
05-04 16:04
Crude Oil Down 3%; Chevron Posts Mixed Q1 Results
Stocks traded mixed, with Dow down 0.1% but NASDAQ up 1.06%. Chevron reported mixed Q1 results. Esperion, Five9, Atlassian soared while Summit, Crescent, LendingTree fell.
05-02 03:39
Nasdaq Jumps Over 1%; Exxon Mobil Posts Upbeat Revenue
US stocks traded higher, with the Nasdaq up 1%. Dow up 0.05%, Nasdaq up 1.13%, S&P 500 up 0.58%. Tech shares jumped 1.6%, energy stocks fell 1.5%.
05-02 02:15
Esperion Stock Pops On Billion-Dollar ARCHIMED Buyout
Esperion Therapeutics shares rise premarket after agreeing to a ~$1.1B acquisition by ARCHIMED, offering $3.16 per share plus milestone payments.
05-01 20:27
Esperion Therapeutics To Be Acquired By ARCHIMED For $3.16 Per Share In Cash Plus Right To Milestone Payments Of Up To $100M
Esperion Therapeutics (NASDAQ:ESPR) ("Esperion," or the "Company"), a commercial-stage biopharmaceutical company dedicated to developing and delivering innovative cardiometabolic and rare/orphan disease therapies,
05-01 19:04
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
